Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · June 03, 2024

Evaluating the Safety and Anatomic Efficacy of Minocycline Therapy for Geographic Atrophy in Patients With AMD

JAMA Ophthalmology

 

Additional Info

JAMA Ophthalmology
Phase 2 Trial Evaluating Minocycline for Geographic Atrophy in Age-Related Macular Degeneration: A Nonrandomized Controlled Trial
JAMA Ophthalmol 2024 Apr 01;142(4)345-355, TDL Keenan, C Bailey, M Abraham, C Orndahl, S Menezes, S Bellur, T Arunachalam, C Kangale-Whitney, S Srinivas, A Karamat, M Nittala, D Cunningham, BG Jeffrey, HE Wiley, AT Thavikulwat, S Sadda, CA Cukras, EY Chew, WT Wong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading